CAMBRIDGE, Mass.--(BUSINESS WIRE)--Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced that seven abstracts were accepted for presentation at the 2013 American Society for Human Genetics (ASHG) Annual Meeting. The abstracts highlight Good Start’s leadership position in next-generation DNA sequencing and present new data that demonstrate the company’s NGS-based carrier screening is able to detect rare and novel mutations not detected by other laboratories. The findings reinforce that the NGS-based technology utilized in the company’s carrier screening test, GoodStart Select™, more accurately detects pathogenic mutations, irrespective of patient ethnicity, and results in fewer missed carriers.
Help employers find you! Check out all the jobs and post your resume.